AgeX Therapeutics, Inc. (AGE) Financials
Stock symbol AGE is outdated, potentially delisted? Maybe it is available on other exchange?
AGE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 12.2 million | 39.9 million |
| June 30, 2023 | 12.3 million | 34.6 million |
| March 31, 2023 | 12.5 million | 32.5 million |
| Dec. 31, 2022 | 3.2 million | 20.6 million |
AGE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -1.9 million | 40000 |
| June 30, 2023 | -2.0 million | 35000 |
| March 31, 2023 | -1.9 million | 70000 |
| Dec. 31, 2022 | -1.3 million | 114000 |
AGE Net Income
No data available :(
AGE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 397000 | - | - |
| June 30, 2023 | 261000 | 10.1 million | - |
| March 31, 2023 | 280000 | 10.0 million | - |
| Dec. 31, 2022 | 645000 | 10.5 million | - |
AGE Shares Outstanding
AGE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 218000 | 2.2 million | - |
| June 30, 2023 | - | 160000 | 1.7 million | - |
| March 31, 2023 | - | 174000 | 2.0 million | - |
| Dec. 31, 2022 | - | 208000 | 1.6 million | - |
AGE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Sept. 30, 2023 | 46000 | 33000 |
| June 30, 2023 | 9000 | 5000 |
| March 31, 2023 | 10000 | 1000 |
| Dec. 31, 2022 | 8000 | 1000 |
AGE
Price: $11.10
52 week price:
Earnings Per Share: -0.38 USD
P/E Ratio: -1.02
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 785
Market Capitalization: 33.2 million